Navigation Links
ALPHAEON Acquires PRN, A Leading Specialty Nutriceutical Company
Date:7/28/2014

IRVINE, Calif., July 28, 2014 /PRNewswire/ -- ALPHAEON Corporation®, a leader in lifestyle healthcare and subsidiary of Strathspey Crown Holdings LLC, announced today that it has acquired Physician Recommended Nutriceuticals (PRN)®, a leading developer of specialty omega-3s, and related products for dry eye and macular degeneration, based in Plymouth Meeting, PA, in a transaction worth up to $55M.

"ALPHAEON's acquisition of PRN brings together world renowned ophthalmologists and a premier physician recommended line of nutriceutical products that benefit patients," said CEO Robert E. Grant. "Over the past 5 years, PRN has established a strong leadership position in the rapidly growing field of evidence-based physician recommended and dispensed nutriceuticals, achieving consistently high double-digit growth over several years. We are very pleased to partner with such a quality organization and leadership team and look forward to maintaining their stand-alone operation just outside of Philadelphia, Pennsylvania. This acquisition brings significant customer synergies to both organizations and is ideally aligned to ALPHAEON's mission to provide best-in-class wellness related products to patients."

PRN's dry eye patent pending formula has the highest bioavailable concentration per serving of purified omega-3 fatty acids and the optimal ratio of 3:1 EPA/DHA. Dry Eye Omega Benefits® has been clinically proven to address the inflammation leading to dry eye and improve the recovery time from refractive and cataract surgery. In a dry eye clinical study, 82% of patients who consumed PRN's re-esterified triglyceride (rTG) omega-3 product for an eight-week period had a positive change in the composition of their meibum, a potential root cause of dry-eye syndrome.

PRN CEO Ken Krieg stated, "ALPHAEON's uniquely customer-centric business approach enables physicians to provide world-class products, addressing patient lifestyle and clinical needs. PRN products are created to offer condition-specific solutions while promoting overall patient wellness and are backed by human clinical efficacy studies. This acquisition is well timed to expand the reach of PRN's evidence-based nutriceuticals through ALPHAEON's platform of physician selected services and industry leading marketing campaigns."

Last year, more than 1,200 ophthalmologists in North America recommended PRN's dry eye products and over 100,000 patients have ordered and used PRN products. ALPHAEON will begin offering the omega-3 products to its approximately 1,000 physician customers, participating in ALPHAEON's customer affinity program, commencing on August 1, 2014.

About ALPHAEON Corporation

ALPHAEON Corporation is a lifestyle healthcare company committed to partnering with board-certified physicians to bring to market and develop highly innovative technologies and services that promote patient wellness, beauty and performance. Ensuring access to leading advancements in lifestyle healthcare, the company fosters deep relationships with leading specialty physicians so patients look their best, feel their best and know they are receiving the best in lifestyle healthcare. For more information, please visit www.alphaeon.com

About Strathspey Crown

Strathspey Crown is a growth equity firm specializing in lifestyle healthcare. Strathspey Crown uniquely partners with board certified physician specialists to bring to market highly innovative technologies and services in the self-pay sector. The firm is founded in partnership with physician investors across three key medical specialties: plastic surgery, ophthalmology and dermatology. For more information visit www.strathspeycrown.com.

About Physician Recommended Nutriceuticals

PRN is a leading developer of condition-specific omega-3 products and nutritional supplements. Developed by doctors and recommended by world-renowned medical thought leaders, PRN's products are supported by medical evidence and offer exceptional quality and purity. Acknowledged on the Inc. 500|5000 list of fastest growing privately held companies for the third consecutive year, PRN has demonstrated three-year revenue growth of 375%.

PRESS CONTACT:

Jenna Mons, Vice President of Marketing and Communications
Tel: 949-284-4523
Email: press@alphaeon.com  

David Krieg, Director of Communications
Tel: 610-276-1954
Email: dkrieg@prnomegahealth.com   

ALPHAEON® is a registered trademark of ALPHAEON
PRN® is a registered trademark of Physician Recommended Nutriceuticals  
Omega Benefits® is a registered trademark of Physician Recommended Nutriceuticals 

Logo - http://photos.prnewswire.com/prnh/20140728/130500


'/>"/>
SOURCE ALPHAEON Corporation
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration
2. ACON Investments Acquires Injured Workers Pharmacy
3. Chiltern acquires Ockham and the companies merge operations
4. Cantel Medical Acquires Sterilator Company, Inc.
5. Data Sciences International acquires Buxco Research Company to expand preclinical research solutions offering
6. BD Acquires Alverix, Inc.
7. Numotion Acquires Specialty Wheelchairs, LLC
8. Aratana Therapeutics Acquires Okapi Sciences NV
9. 180 Medical Acquires Symbius Medical
10. ANI Pharmaceuticals Acquires 31 Generic Drug Products from Teva Pharmaceuticals
11. PTS, Inc. Acquires A1CNow and Expands Product Portfolio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... , Dec. 6, 2016   AlloSource ... cartilage, cellular, bone, skin and soft-tissue allografts for ... , Business Process Manager, for being named to ... Baldrige National Quality Award by the Commerce Department,s ... the organization,s commitment to process excellence. The Baldrige ...
(Date:12/6/2016)... BOSTON , Dec. 6, 2016  BTL ... evaluation proving that its BTL Vanquish ME device ... homogenous energy delivery to the targeted tissue. The ... reduction, 53% higher, with BTL Vanquish ME versus ... providing our physician network and their patients with ...
(Date:12/6/2016)... opioids commonly used for pain management for workplace injuries, employers now ... to nationwide fatalities. The synthetic opioid called U-47700, or ... morphine, resulting in likelihood of addiction, abuse or death. ... , , ... for HMC HealthWorks, explained the opioid drug is less expensive yet ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... One of two inventors from Glen Burnie, Md., ... painful for her. "This is why the co-inventor and I have designed a new ... then created a prototype of the patent-pending AV-AIR, a device that serves as an ...
(Date:12/7/2016)... ... December 07, 2016 , ... A. Kevin Spann Insurance, ... families throughout the Five Boroughs, is launching a charity drive to raise funds that ... the traditions and spirit of marines and Navy FMF Corpsmen. Working closely with the ...
(Date:12/7/2016)... ... ... Sharon Kleyne, host of the nationally syndicated radio program, The Sharon Kleyne ... declared on her radio program in November 2016 the need to educate people about ... leaders in corporate America, they are trying to take advantage of successful algorithms and ...
(Date:12/7/2016)... ... December 07, 2016 , ... Facial plastic surgeon, Dr. John ... by donating a portion of proceeds to two local organizations: North Chicago Animal Control ... & Friends is a team of authorized and trained volunteers who support rescued ...
(Date:12/7/2016)... ... December 07, 2016 , ... Texas Premier ... operations" carried out by unethical locksmith companies and is urging Search Engines to ... According to Texas Premier Locksmith, these fraudulent locksmith services take advantage of consumers ...
Breaking Medicine News(10 mins):